{"brief_title": "A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate", "brief_summary": "This clinical study is investigating AMG 719, an investigational drug, for the treatment of patients who have Rheumatoid Arthritis and who are taking Methotrexate. AMG 719 is a drug which is self-injected beneath the skin (similarly to the way insulin is self-injected by diabetics). Patients on this study are on study for 28-weeks. They visit the study facility at least 11 times while participating in the study.", "condition": "Rheumatoid Arthritis", "intervention_type": "Drug", "intervention_name": "placebo to AMG 719", "description": "Placebo dose given 3 times weekly", "arm_group_label": "Placebo", "criteria": "- Men or women, at least 18 years of age at screening - Diagnosed with Rheumatoid Arthritis, with a disease duration of at least 24 weeks, receiving methotrexate, and having no recent history of substance or alcohol abuse", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00038298.xml"}